Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Clin Cancer Res. 2016 May 25;22(19):4776–4785. doi: 10.1158/1078-0432.CCR-16-0506

Figure 1. Primary Immune Response Summary.

Figure 1

(A) Further development is based on: * >60% of patients being single or f †30% of patients being multi-TUMAP responders. (B) The number of vaccine-induced TUMAP responses is shown for the overall immune evaluable patient population (n=40) as well as for study cohorts. Black lines indicate mean values. For statistical analysis the Mann-Whitney test was used.

Abbreviations: HBV, hepatitis B virus-derived vaccinated marker peptide; TUMAP, tumor associated peptide; VI, vaccine induced.